{"summary": "A helper event that evaluates whether an individual on HIV preâ€‘exposure prophylaxis (PrEP) should continue the regimen, scheduled three months after the initial start or continuation trigger.", "business_intent": "Automate the eligibility assessment for ongoing PrEP treatment, ensuring patients remain on therapy only when clinical and program criteria are met.", "keywords": ["HIV", "PrEP", "continuation decision", "eligibility assessment", "scheduled event", "clinical guidelines", "patient adherence", "risk evaluation"], "summary_hash": "dcf8cb2d4e88", "cached_at": "2026-02-08T14:21:15+00:00"}